Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival

Published:2016-02-08 Issue:10 Volume:57 Page:2342-2350
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Pratt Guy,Thomas Peter,Marden Nicola,Alexander Denis,Davis Zadie,Hussey David,Parry Helen,Harding Stephen,Catovsky Daniel,Begley Joe,Oscier David

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1137291

Reference27 articles.

1. Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia

2. Defining the prognosis of early stage chronic lymphocytic leukaemia patients

3. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

4. Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia

5. Serum Factors Predict Therapeutic Outcome In Patients with Chronic Lymphocytic Leukemia Treated In the CLL8 Trial of the German CLL Study Group (GCLLSG)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Microflow Cytometry-Based Molecular Detection Methods for Improved Future MDS Cancer Diagnosis;Current Issues in Molecular Biology;2024-07-26

2. Expert consensus on the management of chronic lymphocytic leukaemia in Asia;Clinical and Experimental Medicine;2023-02-16

3. The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment;Diagnostics;2021-05-10

4. Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia;Biomarker Research;2020-09-07

5. Prognostic Markers;Hematologic Malignancies;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3